COVID-19 in haematology patients: a multicentre West Midlands clinical outcomes analysis on behalf of the West Midlands Research Consortium

Br J Haematol. 2021 Jan;192(1):e11-e14. doi: 10.1111/bjh.17136. Epub 2020 Nov 5.

Authors

Hana Morrissey¹, Patrick Ball¹, Anandadeep Mandal², Alan Nevil¹, Shankara Paneesha³, Supratik Basu^{1

4}, Farheen Karim⁴, Md Imran Hossain⁵, Neil Phillips⁶, Jahanzeb Khawaja⁴, Jackie Stone⁴, Duncan Murray⁷, Katie Randall⁸, Vidhya Murthy³, Bhuvan Kishore³, Manos Nikolousis³, Guy Pratt², Jeff Neilson⁹, Nick Pemberton¹⁰, Farooq Wandroo¹¹

Affiliations

¹ University of Wolverhampton, Wolverhampton, UK.
² University of Birmingham, Birmingham, UK.
³ Birmingham Heartlands Hospital NHS Trust, Birmingham, UK.
⁴ Royal Wolverhampton NHS Trust, Wolverhampton, UK.
⁵ Royal Blackburn Teaching Hospital, Blackburn, UK.
⁶ University Hospitals of North Midlands NHS Trust, Stoke-on-Trent, UK.
⁷ University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
⁸ South Warwickshire NHS Foundation Trust, Warwick, UK.
⁹ Dudley Group NHS Foundation Trust, Dudley, UK.
¹⁰ Worcestershire Acute Hospitals NHS Trust, Worcester, UK.
¹¹ Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK.

PMID: 33151540
DOI: 10.1111/bjh.17136

No abstract available

Keywords: COVID-19; Haematological Conditions; Haematology patients; Lung infiltrates; SARS-Cov-2.

Publication types

Letter
Multicenter Study

MeSH terms

Aged
Aged, 80 and over
COVID-19 / complications*
COVID-19 / mortality
Comorbidity
Female
Hematologic Diseases / complications*
Hospital Mortality
Humans
Male
Middle Aged
Retrospective Studies
United Kingdom